|
05/05/2021
|
Summary ToggleEledon Pharmaceuticals Announces Upcoming Presentations on AT-1501 at the Virtual 2021 American Transplant Congress
|
|
05/04/2021
|
Summary ToggleEledon Pharmaceuticals to Release First Quarter Financial Results on Thursday, May 13, 2021
|
|
04/26/2021
|
Summary ToggleEledon Pharmaceuticals Announces Update on Development Strategy for AT-1501 in Renal Transplantation
|
|
04/19/2021
|
Summary ToggleEledon Pharmaceuticals Continues to Bolster Leadership Team with Addition of Two More Key Executives
|
|
03/30/2021
|
Summary ToggleEledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Operating and Financial Results
|
|
03/23/2021
|
Summary ToggleEledon Pharmaceuticals to Release Fourth Quarter and Full-Year Financial Results on Tuesday, March 30
|
|
03/15/2021
|
Summary ToggleEledon Pharmaceuticals Strengthens Leadership Team with Chief Medical Officer and Chief Financial Officer Hires
|
|
03/02/2021
|
Summary ToggleEledon Pharmaceuticals to Present at H.C. Wainwright Global Life Sciences Conference
|
|
02/17/2021
|
Summary ToggleEledon Pharmaceuticals to Present at 10th Annual SVB Leerink Global Healthcare Conference
|
|
01/19/2021
|
Summary ToggleEledon Pharmaceuticals to Participate in the Virtual Noble Capital Markets' Seventeenth Annual Investor / Equity Conference
|
